hemmung bei Patienten mit akutem Koronarsyndrom (ACS) - BIK

27. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM,
Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev
I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo
A. Incidence, predictors, and outcome of
thrombosis after successful implantation of drug-eluting stents.
JAMA. 2005;293:2126-2130
28. Wiviott SD, Braunwald E, McCabe CH, Horvath I,
Keltai M, Herrman JP, Van de Werf F, Downey WE,
Scirica BM, Murphy SA, Antman EM. Intensive oral
antiplatelet therapy for reduction of ischaemic events
including stent thrombosis in patients with acute coronary
syndromes treated with percutaneous coronary intervention
and stenting in the TRITON-TIMI 38 trial: A subanalysis of a
randomised trial. Lancet. 2008;371:1353-1363
29. De Servi S, Savonitto S. How to explain the reduced
cardiovascular mortality in the ticagrelor arm of the
PLATO trial? Int J Cardiol. 2011;149:265-267
30. Serebruany VL, Atar D. The PLATO trial:
Do you believe in magic?
Eur Heart J. 2010;31:764-767
27